Allergan/Inamed/Corneal European integration

Allergan-Medical-Aesthetics-Logo-e1439903530236.jpg

  • Led the integration of Allergan, Inamed, Corneal and Endoart, creating Allergan’s Medical Aesthetics business unit

  • Grew top line sales from $186m in 2006 to $300m in 2008, rejuvenating Breast implant and Dermal filler franchises and continuing to grow BOTOX® business despite generic competition

  • Restructured sales forces and service function into integrated, cross portfolio organisation to maximise key account focus and combat market commoditisation

    • Reduced headcount by 15% while increasing growth rates

  • Led the development of the first European Medical Aesthetic Direct to Consumer (TV) advertising campaigns for Juvederm™ Ultra in UK and France